Keros Therapeutics, Inc.KROSNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank71
3Y CAGR+3.3%
5Y CAGR+4.6%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+3.3%/yr
vs +82.9%/yr prior
5Y CAGR
+4.6%/yr
Consistent
Acceleration
-79.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $338.02M | -45.1% |
| 2024 | $615.89M | +66.4% |
| 2023 | $370.02M | +20.6% |
| 2022 | $306.78M | +20.2% |
| 2021 | $255.25M | -5.3% |
| 2020 | $269.44M | +2359.5% |
| 2019 | $10.96M | -60.0% |
| 2018 | $27.41M | - |